Top Priorities for Life Sciences CFOs in 2024
1.0 CPE Credit
In the field of Specialized Knowledge (SK)
Delivery: This webcast will be delivered via the BDO Online CPE Network
Prerequisites: None
Advanced Prep: None
Program Level: Basic
Learning Objectives:
- Review how life sciences CFOs are adjusting their cash management and investing strategies in response to ongoing economic volatility.
- Discuss what tax strategies life sciences CFOs are pursuing to improve their financial standing — and what opportunities they may be missing.
- Describe the treatments and drug modalities that life sciences CFOs will be prioritizing in 2024.
- Explain how life sciences organizations are addressing generative AI risks and concerns, especially those related to data privacy.
BDO USA, P.C., is registered with the National Association of State Boards of Accountancy (NASBA) as a sponsor of continuing professional education on the National Registry of CPE Sponsors. State boards of accountancy have final authority on the acceptance of individual courses for CPE credit. Complaints regarding registered sponsors may be submitted to the National Registry of CPE Sponsors through its website: www.nasbaregistry.org
Amit Bhalla
EVP & CFO, Sampled
Douglas Gustin
Assurance Principal, BDO USA
Harry Palmin
Experienced CFO
Mike Madden
CFO, Lumanity
Sarah Romano
CFO, First Wave BioPharma
NOTE: There is NO CPE for this recording.